Disease-Specific Research Grants

Request for Applications: The Terri Brodeur Breast Cancer Foundation 2009 Granting Process
BACKGROUND:

The Terri Brodeur Breast Cancer Foundation is a nonprofit organization dedicated to providing critical funding to researchers investigating breast cancer cures and patient treatment options. Terri Brodeur, the Foundation’s namesake, was presented with Stage 4 Breast Cancer in June 2003. Effective treatment options did not exist to help Terri. After a two-year battle, marked by courage, grace, and dignity, at the young age of 41 years, Terri succumbed to the disease, leaving behind a beloved husband and three cherished children. The Foundation is founded on the pledge of delivering 100 percent of gross fundraising dollars to breast cancer science. The Foundation’s Grant Program seeks to augment clinical and pre-clinical fellowships in high impact, breast cancer therapeutic research areas.

AWARDS:

This award is intended to support researchers who have received their doctorate to enable them to qualify for an independent career in breast cancer research. The foundations seeks to fund broadly across all relevant disciplines and as such focus areas can include basic, preclinical and clinical research. The award period is for two years with an interim renewal to occur at one year. Stipends are $45,000 per year, with an additional $5,000 allocated for institutional overhead costs.

Foundation awards are intended to support young doctoral researchers, enabling them to more expediently develop independent careers geared toward breast cancer science. The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, the committee will seek to fund as many fellowships as is financially possible

APPLICATION PROCESS:

Prospective applicants are expected to submit a research plan, pre-approved by their prospective supervisor, to the foundation’s Scientific Advisory Committee. The research plan must be fundamentally sound and will include statements of: (a) The scientific and technical merit of the research question; (b) The design, methodology, and feasibility of the study; (c) The relevance of the proposed research plan to the applicant’s career objectives; (d) The medical and health significance of the proposed research to breast cancer prevention, control and/or treatment; and (e) The appropriateness of the research plan as a vehicle for developing necessary research skills. The applicant should also present evidence of the institutional commitment to the development of the applicant; the quality and relevance of the training environment and mentored relationship for the professional development of the applicant; the adequacy of the research facilities and training opportunities for the proposed project; and the appropriateness of the facilities and environmental resources available to the candidate. The application should not exceed 10 pages in length. However, the review committee reserves the option of asking applicants for additional supportive information. Also include a budget, letter(s) of support from appllicant's mentor, and institutional letter of support.

SOURCE OF FUNDS:

The Terri Brodeur Breast Cancer Foundation obtains its funds principally from private and corporate donations collected annually by our volunteers, and through organized fundraising events approved by the Foundation.

DEADLINES:

A preliminary application is mandatory for those applying for a 2009 fellowship grant and must be submitted by October 15, 2008. Proposals should be submitted as a hard copy as well as sent electronically to the addresses given below:

The Terri Brodeur Breast Cancer Foundation
PO Box 785
New London, CT 06320
Attn: Dr. Nicholas A. Saccomano

Saccomano@Bendres.com

Applications will be reviewed promptly by the scientific advisory committee. Depending on the grant, the committee will evaluate applications based on the following criteria: (a) the scientific merit, originality, and feasibility of the application; (b) the qualifications, experience and productivity of the applicant, and the members of the investigative team; (c) the facilities and resources available; and (d) the promise of the research or training as related to the control of breast cancer or to the benefit to be gained by persons with breast cancer. The evaluations of the committee are provided to the Foundation’s Board of Directors. After considering the relative merit of the applications, the amount of available funds and the Foundation’s objectives, the board will determine which grants will be funded. Applications that are not funded may be revised and resubmitted.

NOTIFICATION OF APPLICATION RECEIPT AND REVIEW:

Approximately one month after receipt of the application, the applicant will receive an email acknowledgment confirming receipt of application and an approximate date upon which the committee will communicate a decision back to the applicant.

PUBLICATIONS AND OTHER RESEARCH COMMUNICATIONS:

Publications resulting from research, or training activities supported by the American Cancer Society, must contain the following acknowledgment: "Supported by Terri Brodeur Breast Cancer Foundation”.

Funding Opportunities

The Dystonia Medical Research Foundation (DMRF) encourages and supports research related to the causes, mechanisms, prevention, and treatment of all forms of dystonia, the third most common movement disorder. Through a peer-review process, all applications are reviewed and ranked by the DMRF’s Medical and Scientific Advisory Council, who then make recommendations to the Board of the Directors for funding.

Types of Awards

Fellowships
A two-year Fellowship is designed to assist post-doctoral fellows establish careers in research relevant to dystonia.

The DMRF supports hypothesis-driven research at the genetic, molecular, cellular, systems, or behavioral levels that may lead to a better understanding of the pathophysiology of dystonia or to new therapies for dystonia.

Funding for fellowships is $50,000 per year for two years.

Research Grants
Research grants are available in support of hypothesis-driven research at the genetic, molecular, cellular, systems, or behavioral levels that may directly or indirectly lead to a better understanding of the pathophysiology and to new therapies for any or all forms of dystonia. Although early-onset primary generalized dystonia is of special interest, we also support studies on the focal dystonias, including laryngeal dystonia/spasmodic dysphonia, as well as secondary dystonias.

Funding for grants is available up to $65,000 per year for 1 or 2 years.

The deadline for grant and fellowship applications is December 15, 2008. Applications and guidelines will be available September 15.

Dystonia Medical Research FoundationNational Headquarters
One East Wacker Drive, Suite 2810
Chicago, Illinois 60601-1905
Phone: 312-755-0198
Toll free: 800-377-DYST (3978)
In Canada: 800-361-8061
Fax: 312-803-0138
Email: dystonia@dystonia-foundation.org

The Sidney Kimmel Foundation for Cancer Research utilizes an on-line application available at www. kimmel.org/cancerresearch. Problems or questions about the application process may be address to kfletche@gbmc.org.

Kimmel Scholar Award

To select the grant recipients, the Sidney Kimmel Foundation for Cancer Research has created a Medical Advisory Board consisting of distinguished cancer researchers. Each year the Kimmel Foundation expects to select up to ten grant recipients who will receive $100,000 per year for two years. Qualified applicants must hold an M.D., Ph.D. or equivalent graduate degree and must perform research in an American not-for-profit institution during the period of Kimmel Foundation support.

The Kimmel Foundation is seeking accomplished young investigators dedicated to a career in cancer research. Applications are limited to those who achieved the equivalent rank of Assistant Professor on or after July, 2005. However, physicians who have both clinical and research responsibility are eligible if appointed on or after July, 2004. These awards are designed for researchers who do not yet have their own R01 funding. Applicants will be judged on the basis of quality of prior work, research proposed and letters of support. Funding of awards will be subject to execution of binding agreements setting forth terms and conditions under which scholarships will be provided. Applicants for 2009 awards will be notified by mid-April, 2009.

The Kimmel Translational Science Award

The Foundation provides five additional awards specifically for physicians engaged in translational science. Eligibility includes those with M.D. or equivalent degrees, who have achieved the rank of Assistant Professor on or after July, 2004. Candidates must not hold R01 funding for the laboratory component of their cancer research. Applicants must demonstrate a significant personal involvement in the laboratory component of the translational project described. The translational research may involve primarily animal studies but must include reasonable application to subsequent human investigation.

Each application consists of the following:

Personal Statement (1-2 pages)

Please provide a statement about career objectives as they relate to cancer research and explain how your work satisfies the mission of The Sidney Kimmel Foundation for Cancer Research. The statement should include a description of the work environment and necessary resources available to conduct research and a statement of the approximate percent of effort to be devoted to research, teaching, patient care, administration, and other duties. Be sure to explain how your research will aid our understanding and treatment of human malignant diseases. Attach curriculum vitae.

Research (limit narrative to 3 pages)

Please describe your work in cancer research, including a brief description of pertinent supporting studies. Outline the future direction of current research and include other potential areas of interest. Explain the importance of your work to our understanding of cancer and implications for future therapies of malignant disease or cancer prevention. Graphs, figures, tables and references may be uploaded to the appendix section or included within the narrative.

Budget (1 page)

The Kimmel Scholar Award provides $100,000 per year for two years. The Kimmel Foundation will not provide additional institutional overhead but part of the grant may be budgeted toward overhead costs. The Foundation requests that institutions limit overhead to 15% or less. Please approximate the manner in which funds will be allocated among categories such as salary support, research, equipment, travel, administrative costs, etc. Also describe in detail all other current and pending funding including source, amount and duration of such support. The Foundation will not consider applicants who are already fully funded by R01 grants or who are currently the beneficiary of another similar scholar award which supports cancer research.

Personal References (1-2 pages each)

Please provide three letters of reference. The on-line application will generate a request to your references asking for a letter on your behalf. One letter must be from the Chairman of your Division or Department, and two from appropriate physicians and/or scientists who are familiar with your work. Letters may be sent under separate cover but must be received by December 31. Letters should broadly review the independence and importance of the applicant's work in the context of similar work from other laboratories. Rank the independence and quality of the work, within the reviewer's experience. Assess the overall contribution of the applicant in published papers which involved collaboration with senior investigators.

Appendix

Please supply up to three original papers (authored by applicant) from peer reviewed journals. If available, submit one or more papers or editorials from other sources which elucidate the background or importance of your work (helpful, but not required).

Cover Page (1 page)

Each application should include the standardized cover page, which will be automatically generated upon completion of the on-line application. Please print a copy of the cover page, sign and attach with the hardcopies to be mailed. The cover page should be completed with appropriate demographic information, as requested. Please provide an abstract of the current research and a brief explanatory title. An institutional official who is responsible for budget oversight must also personally sign the cover page for submission to the Foundation. Electronic signatures or copies will not be acceptable.

Completed Applications

The full on-line application should include the standardized cover page, description of research, personal statement, three letters of recommendation, budget and curriculum vitae. Please also supply a signed original and one copy of the application by mail within two days of completed on-line submission. Also include copies of appendix (samples of investigator's and relevant supporting published work). On-line applications must be completed by Wednesday, December 3, 2008 at noon EST. Letters of reference must be submitted preferably by reply email to The Foundation by December 31.

Please submit to:

Gary I. Cohen, M.D.
Cancer Center at GBMC
6569 North Charles Street, Suite 201
Baltimore, MD 21204

Friends For An Earlier Breast Cancer Test awards funding and grants for cancer research that demonstrates the potential for discovering earlier methods of breast cancer detection, such as a biological test. Through breast cancer funding research with specifically focused seed money grants, money directed from Friends is leveraged to help researchers pursue promising ideas. As a result of this preliminary work, it can be determined if research projects should be continued, ended, or altered. Our Medical Advisory Board annually selects the most worthy projects to receive funding. Without the opportunity for exploration worthy of new ideas, the disease of breast cancer can only change incrementally.

Deadline for application is December 1st.

Telephone:
Toll free: 888-792-3062
Local: 336-286-6620
Fax: 336-286-6680

Email:
Business Office: friends@earlier.org

Klarman Family Foundation Grants Program in Eating Disorders Research
Program Officer: Gay Lockwood 617-279-2240 ext. 702

The Klarman Family Foundation Grants Program in Eating Disorders Research was established in 2008 to expand the number of outstanding scientists whose research explores the basic biology of anorexia nervosa, bulimia nervosa and/or binge eating disorder. The long term goal is to accelerate progress in developing effective treatments for these disorders. Examples of funding areas include but are not limited to molecular genetic analysis of relevant neural circuit assembly and function; animal models created by genetically altering neural circuits; testing of new chemical entities that might be used in animal models as exploratory treatments; and brain imaging approaches that identify neurochemical pathways in patients with these disorders. Clinical psychotherapeutic studies, medication trials and research in the medical complications of eating disorders are currently outside the scope of this Program.

For the 2009 cycle, two-year awards of $400,000 ($200,000 per year inclusive of 10% indirect costs) and one-year pilot studies of up to $150,000 (inclusive of 10% indirect costs) will be made to investigators with a faculty appointment at a nonprofit academic, medical or research institution in the United States, Canada or Israel. Eligibility is not limited to those investigators currently working in eating disorders research.

The next application deadline for the Initial Proposal Application is November 20, 2008 for awards beginning on June 1, 2009. Applications will be accepted through an online submission process.

Medical Research Grants Division
The Medical Foundation
95 Berkeley Street, Suite 208
Boston, MA 02116

Prize4Life announced its 2-year $1 million ALS/MND Biomarker Challenge on November 6, 2006.

The Prize4Life Biomarker Prize is divided into two tracks - theoretical findings and real outcomes.

The first track was a call for scientists and researchers from all backgrounds to submit theoretical papers on how they would develop a biomarker for ALS. In May 2007, Prize4Life awarded $15,000 for each of the five best ideas submitted . This track is now closed for submissions.

The second track, currently running, involves identifying an actual ALS biomarker. Anyone can submit a solution to the second track at any time, regardless of whether they participated in the first track.

A prize of up to $1,000,000 will be awarded in track two for the first validated ALS biomarker submitted that meets the desired requirements. Those submitting a solution must provide statistically significant results as proof of the validity of the solution. This challenge will end in November 2008 if a winning solution is not received so send in your solution now!!

A biomarker is a distinctive biological or biologically derived indicator that can mark the presence and/or progression of a disease. A biomarker can take the form of a chemical marker, a mechanical device that measures relevant physiological changes, or combination of the two. Currently, there are no known biomarkers for ALS for either diagnosing or measuring the progression of the disease.

Interested scientists and researchers should REGISTER with Prize4Life.

INNOCENTIVE 4470259
ALS Biomarker
POSTED: NOV 06, 2006
DEADLINE: NOV 06, 2008
$1,000,000 USD

Visiting Scientist Award

The IARC is offering a Visiting Scientist Award for a qualified and experienced investigator with recent publications in international peer-reviewed scientific journals who wishes to spend from six to twelve months at the IARC working on a collaborative project in a research area related to the Agency's programmes: epidemiology, biostatistics, environmental chemical carcinogenesis, cancer etiology and prevention, infection and cancer, molecular cell biology, molecular genetics, molecular pathology and mechanisms of carcinogenesis.

Candidates are requested to contact the relevant Scientific Groups in order to set up a collaborative project. For details on scientific programmes and research groups please consult the IARC Web site: http://www.iarc.fr/en/Research-Groups/Clusters-Groups, or contact the IARC at the address below.

Applicants must belong to the staff of a university or a research institution and should provide written assurance of a post to return to at the end of the period of award.
Deadline for receipt of applications is: 30 November 2008

Candidates will be notified of the outcome of their application by the end of April 2009. There will be an annual remuneration of up to US$80,000-, which will take into account the on-going salary of the visiting scientist plus the cost of travel. The Award should be taken up no later than 30 November 2009.

Fellowship application forms and more detailed information are available from:

Fellowship Programme
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC)
150 cours Albert-Thomas, 69008 Lyon, France
Tel: +33 (0)472 73 84 48; Fax: +33 (0)472 73 80 80; E-mail: vsa@iarc.fr

APA/AstraZeneca Young Minds in Psychiatry International Award

Purpose
The APA/AstraZeneca Young Minds in Psychiatry International Awards Program is a commitment by the American Psychiatric Association (APA) and AstraZeneca to recognize and support promising international young psychiatrists within 5 years of completing a psychiatric residency. This year, four unrestricted career development awards of $45,000 (USD) will be available. Awards will be made to two promising physicians from the US with one in Bipolar Disorder research and one on research in Schizophrenia. The U.S. applicants must be citizens or permanent residents of the United States. An additional two awards will be made to promising physicians from countries outside the US with one in Bipolar Disorder research and one on research in Schizophrenia.

Three other awards of $30,000 (USD) in either Bipolar Disorder or Schizophrenia research will specifically focus on applicants from developing countries whose economies are classified by the World Bank as low income or lower middle income. In 2006, the World Bank classified 53 countries as low income with a per capita income of $905 or less. These countries are listed in the following web site: http://www.worldbank.org/data/countryclass/classgroups.htm#low_income. Another 55 countries have been classified as lower middle income with a per capita income of $906 to $3,595 and are listed in the following web site: http://www.worldbank.org/data/countryclass/classgroups.htm#lower_middle_income

To enter the Awards Program candidates are invited to submit a proposal of scientific merit demonstrating academic promise and how winning an Award will assist in the advancement of their career. Proposals can cover a range of activities including research, educational efforts, travel, salary support and materials.

Eligibility
Invitations to apply for the APA/AstraZeneca Young Minds in Psychiatry International Awards are extended to young physician researchers (up to five years post-residency) working in core psychiatric areas with an emphasis on Bipolar Disorder and Schizophrenia. U.S. applicants must also be a member of the APA. International applicants do not need to be members of the APA before applying - awardees will receive international APA member benefits.

Selection
The goals of the Awards are to recognize and support future leaders in Psychiatry and foster innovation through career development. Awards will be granted based on merit. APA claims no rights to the intellectual property of the applicant's research. APA and AstraZeneca reserve the right to use the researcher's name and institution name for public relations purposes. Applicants must demonstrate:

Evidence of academic promise
How the proposal will advance the applicant's career
Innovative or original concepts, approaches or methods of developing applicant's career

Winning proposals will be subject to Institutional Review Board (IRB) approval (if applicable). Proposal should be printed in a minimum of 10-point type, with 1-inch (2.5 cm) margins on all sides and one full space between lines, no longer than three pages including references.

APA/AstraZeneca Young Minds in Psychiatry International Awards Application Form

Applications are available through American Psychiatric Association, APA Web site at this address:

http://www.psych.org/MainMenu/Research/ResearchTrainingandFunding/ResearchFellowships/APAAstraZenecaYoungMindsinPsychiatryInternationalAward/AstraZenecaAwardApplicationForms.aspx

AstraZeneca representatives or the AstraZeneca corporate Web site at www.astrazeneca.com/youngminds/. Please submit one original copy of the following items in ENGLISH via government postal service or overnight courier to the address below:

Completed application form
Curriculum vitae (per form from web site)
Proposal with the following elements:
- Award Utilization
- Title
- Summary
- Rationale
- Proposed activity
- Proposed utilization of funds
- Career Development
- What are your career development plans?
- How winning a Young Minds in Psychiatry Award advance your career?
- Funding support form (per form from web site)
- Letter of recommendation from supervisor or equivalent.

Annual Deadline for Receipt of Application: October 31

Submit All Materials to:
Darrel A. Regier, M.D., M.P.H.
APA/AstraZenca Young Minds in Psychiatry
American Psychiatric Association
1000 Wilson Blvd., Ste. 1825
Arlington, VA 22209-3901.

For additional information, contact Ernesto Guerra at e-mail: eguerra@psych.org

Sheila Essey Award - An Award for ALS Research
Presented by the AAN and the ALS Association and supported through the philanthropy of the Essey family and the ALS Association.

This award recognizes an individual who has made significant research contributions in the search for the cause, prevention of, and cure for amyotrophic lateral sclerosis (ALS). The criteria being used to determine the recipient include recent major scientific impact, long-term scientific impact, and overall impact to ALS.

Presentation
Recipient is expected to present a 20-minute lecture during an anterior horn scientific session at the 61st AAN Annual Meeting.

Recipient will receive:
Certificate of recognition and $25,000 prize to be used by recipient to continue ALS research
Complimentary registration for 61st Annual Meeting
Recognition at 2009 Awards Luncheon at 61st Annual Meeting
Eligibility
Must be actively engaged in ALS research

Application Procedure
Applicants should submit one complete set of the following materials:

Completed application form Note: Under general description: describe how scientific contributions have created a better understanding of ALS; why applicant should receive award; and why contributions represent a major advance or hold significance in ALS research in terms of identifying the cause, potential treatment, prevention, or cure.
Current curriculum vitae
Supporting information (not to exceed three pages), including:
Single page biography including previous positions and any awards or recognition received
One- to two-page listing of six to ten peer-reviewed journal references that support statements about contributions to ALS research (do not send reprints or a bibliography)

Deadline

The deadline to apply for 2009 AAN Scientific Awards is November 3, 2008. Applications will be available in August 2008.

For more information, please contact Naomi Soderbeck at nsoderbeck@aan.com or (651) 695-2814.

AACR Award for Outstanding Achievement in Cancer Research

Nominations for the 2009 Award will open in September 2008
Nomination deadline: 4:00 p.m. United States Eastern Standard Time on Wednesday, October 15, 2008.

The Award & Lecture
Through the generous contribution of an anonymous donor, the AACR established this Award in 1979 to give recognition to a young investigator on the basis of meritorious achievement in cancer research. In accordance with the wishes of the donor, the recipient must be no more than 40 years of age by the time the award is received.

The winner of the 29th Annual AACR Award for Outstanding Achievement in Cancer Research will receive an honorarium of $5,000 and give a 50-minute lecture during the AACR 100th Annual Meeting in Denver, CO, USA (April 18-22, 2009.)

Eligibility
Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
The Award will be presented to an individual investigator.
Institutions or organizations are not eligible for the Award.
Candidates must not be more than 40 years of age by the time the Award is received. For the 2009 Award, a candidate's date of birth must be on or after April 18, 1968.
Nomination Process
Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nomination letters must be sent electronically to the AACR by Wednesday, October 15, 2008 at 4:00 p.m., United States Eastern Time. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days

The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words. The content should include the following:

the name of the AACR Award for which the candidate is being nominated;
a brief statement of no more than 50-words summarizing the candidate's cancer research accomplishment(s) for which he or she is being nominated;
a concise description of the candidate's outstanding cancer research accomplishments in the fields of epidemiology, biomarkers, and prevention, with the publications supporting these accomplishments directly referenced within the letter; and
a concise description of the impact of these accomplishments on the field.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Selection
Candidates for the Award will be considered by a prestigious international Selection Committee of renowned cancer leaders appointed by the President of the AACR. The Committee will consider all nominations as they have been submitted; the Committee may not combine submitted nominations, add a new candidate to a submitted nomination, or otherwise make alterations to the submitted nominations. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and determination.

Selection of the Award winner will be made on the basis of the candidate's meritorious achievements in cancer research. No regard will be given to race, gender, nationality, or religious or political view.

Questions?
Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404